Back to Blog

Can Supplements Prevent Myopia Progression in Children?

February 19, 2026·6 min read

Myopia (nearsightedness) has become one of the defining health trends of the 21st century. Globally, prevalence has nearly doubled since the 1970s. In some East Asian countries, myopia rates in urban adolescents now exceed 80–90%. The condition is not merely an inconvenience — high myopia (above -6 diopters) significantly increases the lifetime risk of retinal detachment, glaucoma, macular degeneration, and cataracts.

Parents, understandably, want to know whether supplements can slow or prevent myopia progression in their children. The honest answer is that supplements are a distant second to behavioral interventions, but some evidence exists worth examining.

The near-work and myopia connection

The association between near work (reading, screens, studying) and myopia development has been debated for decades. The evidence is suggestive but not conclusive as a direct cause — many highly educated adults in East Asia do intensive near work without becoming severely myopic, and some children who spend little time on screens still develop myopia.

The more convincing evidence points to indoor time versus outdoor time as the critical variable, with near work being a confounding factor.

Outdoor time: the strongest intervention by far

The most replicated finding in myopia prevention research is that time outdoors reduces both the incidence of new myopia and, to a lesser degree, the progression of existing myopia. A landmark 2012 randomized intervention study in Taiwan found that schoolchildren assigned to 80 minutes of outdoor time per school day had 9.8% myopia incidence at one-year follow-up versus 17.7% in the control group — approximately a 50% reduction.

Meta-analyses consistently confirm this finding. The effect appears to require approximately 2 hours of outdoor light exposure per day to be protective.

The mechanism is most likely dopamine release stimulated by bright light intensity, which inhibits axial elongation of the eye — the anatomical change responsible for myopia. Indoor light, even with screens on, is typically 50–500 lux; outdoor daylight is 10,000–100,000 lux. This massive intensity difference appears to be the critical factor, not ultraviolet radiation (sunglasses do not eliminate the protective effect).

Dopamine and the myopia connection

Dopamine release in retinal amacrine cells, stimulated by bright light, signals the eye to slow axial elongation. This is the primary reason outdoor light is protective. Animal models show that pharmacological dopamine agonists reduce myopia development, and that dopamine antagonists accelerate it.

This mechanism is also why low-dose atropine eye drops (0.01–0.05%) are among the most effective pharmacological interventions for myopia control — atropine has dopaminergic effects beyond its muscarinic blocking action. It reduces myopia progression by 50–77% in RCTs, with the 0.01–0.025% dose showing the best balance of efficacy and side effects.

Vitamin D: association but uncertain causation

Multiple epidemiological studies have found that vitamin D deficiency is associated with higher rates of myopia. Countries with low sunlight exposure and indoor lifestyles have both high myopia rates and high vitamin D deficiency rates — and both correlate with reduced outdoor time.

The problem is confounding: the same behavior (staying indoors) causes both vitamin D deficiency and myopia risk. Whether vitamin D has an independent biological role in eye growth is unclear. A few small interventional studies have not found that vitamin D supplementation alone reduces myopia progression when outdoor time is controlled for.

Practical recommendation: correct vitamin D deficiency (target serum 25-OH-D above 30 ng/mL) for general health reasons, but do not rely on supplemental vitamin D as a myopia intervention.

Omega-3 fatty acids: limited evidence

DHA is the predominant fatty acid in the retina and plays roles in photoreceptor membrane function and retinal signaling. Some animal research has found that omega-3 deficiency is associated with altered eye development. Population studies in some Asian cohorts found associations between dietary fish/omega-3 intake and lower myopia prevalence.

However, interventional RCTs specifically testing omega-3 for myopia control are lacking. The evidence is insufficient to recommend omega-3 supplementation specifically for myopia prevention, though omega-3 remains reasonable for general retinal and cognitive health.

Lutein and zeaxanthin

Lutein and zeaxanthin support macular pigment density and retinal antioxidant status. There is no strong evidence they slow myopia progression. They are worthwhile for retinal health generally — particularly given the elevated AMD risk that accompanies high myopia later in life — but not as primary myopia control interventions.

What effective myopia control actually looks like

Proven or evidence-supported interventions for myopia control in children, ranked by strength of evidence:

  1. Outdoor time (2+ hours daily): Strongest preventive evidence, 50% reduction in new cases
  2. Low-dose atropine eye drops (0.01–0.05%): Effective at slowing progression 50–77%, requires prescription
  3. Orthokeratology (Ortho-K): Custom overnight contact lenses that reshape the cornea; reduces progression 30–50%
  4. Multifocal soft contact lenses: Some evidence for progression control
  5. Progressive addition glasses: Modest and inconsistent evidence
  6. Supplements: No intervention-level evidence for myopia control specifically

Screen time and myopia: the nuanced picture

The popular belief that screen time causes myopia is an oversimplification. Screen time displaces outdoor time — this is likely the primary mechanism of any screen-myopia association, not the screens themselves. Reading a book indoors for 2 hours has similar effects to a screen for 2 hours from a myopia-risk perspective. Outdoor reading, conversely, appears protective compared to indoor reading, despite the same near-work demand.

Practical family guidance

For families concerned about myopia progression:

  • Prioritize 2 hours of outdoor time daily — the most impactful intervention
  • If myopia has begun progressing, consult a pediatric ophthalmologist about atropine or orthokeratology
  • Supplement vitamin D if deficient (test and treat to sufficiency)
  • Omega-3 at age-appropriate doses (500–1000mg EPA+DHA/day for children) is reasonable for general health
  • Set realistic expectations: no supplement will substitute for the behavioral change of going outside

The bottom line

No supplement meaningfully controls myopia progression in children based on current evidence. Outdoor time at 2+ hours daily reduces new myopia by approximately 50% — this behavioral intervention dwarfs anything in a capsule. Supplements like vitamin D and omega-3 support general health but are not myopia-specific interventions.


To understand what evidence-based eye health support looks like for your family, Use Optimize free.

Related Articles

Want to optimize your health?

Create your free account and start tracking what matters.

Sign Up Free